Maria Foggia

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.

Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.

Journal: Infectious diseases (London, England)

Published: September 05, 2025

COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.

COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.

Journal: BMC cancer

Published: January 23, 2024

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab.

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab.

Journal: Virology journal

Published: October 01, 2023

Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.

Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.

Journal: Journal of fungi (Basel, Switzerland)

Published: July 08, 2023

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study.

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study.

Journal: Infectious diseases and therapy

Published: May 29, 2023

Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study.

Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study.

Journal: Vaccines

Published: December 06, 2022

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19.

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19.

Journal: Vaccines

Published: October 19, 2022

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience.

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience.

Journal: Heliyon

Published: September 11, 2022

COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study.

COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study.

Journal: Le infezioni in medicina

Published: August 11, 2022

Should SARS CoV-2 Infection be Considered an Independent Risk Factor for Pneumocystis jirovecii Pneumonia? Emerging Data after Two Years of Pandemic from a Single Center Experience.

Should SARS CoV-2 Infection be Considered an Independent Risk Factor for Pneumocystis jirovecii Pneumonia? Emerging Data after Two Years of Pandemic from a Single Center Experience.

Journal: Reviews on recent clinical trials

Published: February 28, 2022

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience.

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience.

Journal: Frontiers in medicine

Published: January 28, 2022

mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study.

mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study.

Journal: Frontiers in medicine

Published: January 11, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026